Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.8%

1 terminated out of 36 trials

Success Rate

90.0%

+3.4% vs benchmark

Late-Stage Pipeline

22%

8 trials in Phase 3/4

Results Transparency

22%

2 of 9 completed with results

Key Signals

2 with results90% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (6)
P 1 (2)
P 3 (1)
P 4 (7)

Trial Status

Recruiting17
Completed9
Not Yet Recruiting8
Withdrawn1
Terminated1

Trial Success Rate

90.0%

Benchmark: 86.6%

Based on 9 completed trials

Clinical Trials (36)

Showing 20 of 20 trials
NCT07111494Phase 4RecruitingPrimary

Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial

NCT07744191Phase 4Not Yet Recruiting

A Clinical Trial of Antiplatelets in Psoriasis

NCT03671148Phase 3CompletedPrimary

A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)

NCT07087912Phase 4Recruiting

Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases

NCT07277491Completed

Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease Activity

NCT07455578Phase 1Recruiting

Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease

NCT07611747Phase 4Recruiting

Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)

NCT07443956Not ApplicableRecruitingPrimary

Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis

NCT07536529Recruiting

Oxidative Stress in Autoimmune Rheumatic Diseases

NCT03768271Recruiting

APACHE Cohort (A Psoriatic Arthritis CoHort)

NCT06990152Not ApplicableCompletedPrimary

A Randomized, Double-blind Clinical Trial on the Efficacy of a Dietary Formulation Containing Medium-chain Triglycerides (MCT) and Fiber in Patients With Psoriatic Arthritis

NCT07280702Phase 4Not Yet RecruitingPrimary

Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease

NCT07486843Phase 4RecruitingPrimary

Preventing Structural Damage in Early Psoriatic Arthritis

NCT07460739Not ApplicableNot Yet Recruiting

Efficacy of a Self-Management Smartphone App to Improve Safety Skills in Patients With Inflammatory Arthritis

NCT04541810Completed

A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis

NCT04806620Recruiting

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

NCT07298265Recruiting

Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis

NCT05421442Completed

A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database

NCT06628206Phase 1Recruiting

Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis

NCT07188285Not Yet Recruiting

Mass Spectrometry-based Immune Profiling in Autoimmune Diseases

Scroll to load more

Research Network

Activity Timeline